Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease

BACKGROUND: Although the eradication of Helicobacter pylori is of primary importance when initiating treatment, it is also important to have a strategy for patients who are H pylori-negative, fail to demonstrate eradication or have a tendency to become re-infected or relapse.

Saved in:
Bibliographic Details
Main Authors: K Lauritsen, K Rutgersson, E Bolling, G Brunner, S Eriksson, JP Galmiche, A Walan, AP Archambault, H Gudjónsson, RJ Bailey, G Bianchi Porro, L Frison, N Havu, ABR Thompson
Format: Article
Language:English
Published: Wiley 1999-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/1999/395876
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553522764185600
author K Lauritsen
K Rutgersson
E Bolling
G Brunner
S Eriksson
JP Galmiche
A Walan
AP Archambault
H Gudjónsson
RJ Bailey
G Bianchi Porro
L Frison
N Havu
ABR Thompson
author_facet K Lauritsen
K Rutgersson
E Bolling
G Brunner
S Eriksson
JP Galmiche
A Walan
AP Archambault
H Gudjónsson
RJ Bailey
G Bianchi Porro
L Frison
N Havu
ABR Thompson
author_sort K Lauritsen
collection DOAJ
description BACKGROUND: Although the eradication of Helicobacter pylori is of primary importance when initiating treatment, it is also important to have a strategy for patients who are H pylori-negative, fail to demonstrate eradication or have a tendency to become re-infected or relapse.
format Article
id doaj-art-165a5db58c974870966171236b77b51b
institution Kabale University
issn 0835-7900
language English
publishDate 1999-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-165a5db58c974870966171236b77b51b2025-02-03T05:53:45ZengWileyCanadian Journal of Gastroenterology0835-79001999-01-01131080681310.1155/1999/395876Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer DiseaseK Lauritsen0K Rutgersson1E Bolling2G Brunner3S Eriksson4JP Galmiche5A Walan6AP Archambault7H Gudjónsson8RJ Bailey9G Bianchi Porro10L Frison11N Havu12ABR Thompson13Odense University Hospital, DenmarkAstra Hässle AB, Mölndal, SwedenAstra Hässle AB, Mölndal, SwedenMedizinische Hochschule Hannover, GermanyMedizinische Hochschule Hannover, GermanyHôpital Guillaume et René Laënnec, Nantes, FranceAstra Hässle AB, Mölndal, SwedenUniversity Hospital, Montreal, CanadaLandspítalinn, Reykjavík, IcelandRoyal Alexandra Hospital, Edmonton, Alberta, CanadaOspedale “L Sacco”, Milano, ItalyAstra Hässle AB, Mölndal, SwedenAB Astra, Södertälje, SwedenUniversity of Alberta, Edmonton, Alberta, CanadaBACKGROUND: Although the eradication of Helicobacter pylori is of primary importance when initiating treatment, it is also important to have a strategy for patients who are H pylori-negative, fail to demonstrate eradication or have a tendency to become re-infected or relapse.http://dx.doi.org/10.1155/1999/395876
spellingShingle K Lauritsen
K Rutgersson
E Bolling
G Brunner
S Eriksson
JP Galmiche
A Walan
AP Archambault
H Gudjónsson
RJ Bailey
G Bianchi Porro
L Frison
N Havu
ABR Thompson
Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
Canadian Journal of Gastroenterology
title Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
title_full Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
title_fullStr Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
title_full_unstemmed Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
title_short Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
title_sort omeprazole and ranitidine in the prevention of relapse in patients with duodenal ulcer disease
url http://dx.doi.org/10.1155/1999/395876
work_keys_str_mv AT klauritsen omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT krutgersson omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT ebolling omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT gbrunner omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT seriksson omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT jpgalmiche omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT awalan omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT aparchambault omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT hgudjonsson omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT rjbailey omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT gbianchiporro omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT lfrison omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT nhavu omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease
AT abrthompson omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease